Shinde, Paurvi <br/><br/>
Understanding how combinatorial targeting of TLRs and TNFR family costimulatory members promote enhanced T cell responses.  [electronic resource] 

 -  Expert opinion on biological therapy  10 2018 
 - 1073-1083 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Review 
<br/><br/><label>ISSN: </label>1744-7682 
<br/><br/><label>Standard No.: </label>10.1080/14712598.2018.1518422  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--pharmacology<br/>Animals<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Cancer Vaccines--pharmacology<br/>Combined Modality Therapy<br/>Drug Delivery Systems--methods<br/>Humans<br/>Immunity, Cellular--drug effects<br/>Lymphocyte Activation--drug effects<br/>Receptors, Tumor Necrosis Factor--antagonists & inhibitors<br/>T-Lymphocytes--drug effects<br/>Toll-Like Receptors--antagonists & inhibitors